Release date: 7 September 2007
Promoter – Financial Intermediary
Getinge AB
Location
Description
The project concerns the part-financing of Getinge Group’s annual R&D expenditures in the 2007-2010 period.
Objectives
The project aims at maintaining and further developing Getinge’s leading position in the fields of medical care and technology.
Comments
Article 267, point (c)
Sector(s)
Proposed EIB finance (Approximate amount)
Loan up to SEK 500 million. (EUR 54 million)
Total cost (Approximate amount)
Approximately SEK 1 billion. (EUR 109 million)
Environmental aspects
The execution of the RDI programme will have no material environmental impact. All national and EU environmental legislation will be respected.
Procurement
The promoter is a private company and therefore not bound by EC Directives on procurement.
Status
Signed - 19/06/2008
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).